A phase I/II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer

被引：0
|
作者：
Kyoung Ha Kim
Young Suk Park
Myung Hee Chang
Hyo Song Kim
Hyun Jung Jun
Jieun Uhm
Seong Yoon Yi
Do Hyoung Lim
Sang Hoon Ji
Min Jae Park
Jeeyun Lee
Se Hoon Park
Joon Oh Park
Ho Yeong Lim
Won Ki Kang
机构：
[1] Samsung Medical Center,Division of Hematology
[2] Sungkyunkwan University School of Medicine,Oncology, Department of Medicine
来源：
Cancer Chemotherapy and Pharmacology | 2009年 / 64卷
关键词：
Docetaxel; Oxaliplatin; Advanced gastric cancer; Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：347 / 353
页数：6
相关论文
共 50 条
  • [41] A randomized phase II study of weekly docetaxel/cisplatin versus weekly docetaxel/oxaliplatin as first-line therapy for patients with advanced gastric cancer
    Young Saing Kim
    Sun Jin Sym
    Se Hoon Park
    Inkeun Park
    Junshik Hong
    Hee Kyung Ahn
    Jinny Park
    Eun Kyung Cho
    Woon Ki Lee
    Min Chung
    Jae Hoon Lee
    Dong Bok Shin
    Cancer Chemotherapy and Pharmacology, 2014, 73 : 163 - 169
  • [42] Docetaxel, oxaliplatin, and capecitabine (TEX regimen) in patients with advanced or metastatic gastric or gastroesophageal cancer (GC): Results from a phase II trial of the German AIO group
    Arnold, D.
    Thuss-Patience, P. C.
    Stein, A.
    Grothe, W.
    Seufferlein, T.
    Reinacher-Schick, A.
    Geisaler, M.
    Hofheinz, R.
    Moehler, M. H.
    Schmoll, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [43] Phase II trial of miniDOX (reduced dose docetaxel-oxaliplatin-capecitabine) in "suboptimal" patients with advanced gastric cancer (AGC). TTD 08-02
    Rivera, F.
    Massuti, B.
    Salcedo, M.
    Sastre, J.
    Martinez Galan, J.
    Valladares-Ayerbes, M.
    Serrano, R.
    Garcia de Paredes, Ma L.
    Manzano, J. L.
    Galan, M.
    Alsina, M.
    Yuste Izquierdo, A. L.
    Lopez, C.
    Diaz-Rubio, E.
    Conde, V.
    Reboredo, M.
    Cano, Ma T.
    Pachon, V.
    Aranda, E.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (02) : 319 - 324
  • [44] Phase II trial of miniDOX (reduced-dose docetaxel/oxaliplatin/capecitabine) in "suboptimal" patients with advanced gastric cancer (AGC): TTD 08-02
    Rivera, Fernando
    Massuti, Bartomeu
    Salcedo, Matilde
    Sastre, Javier
    Martinez-Galan, Joaquina
    Valladares-Ayerbes, Manuel
    Serrano, Raquel
    Garcia De Paredes, Marisa
    Tabernero, Josep
    Carmen Galan, M.
    Manzano Mozo, Jose Luis
    Diaz Rubio, Eduardo
    Conde, Veronica
    Reboredo, Margarita
    Vazquez, Silvia
    Layos Romero, Laura
    Ramos Pascual, Francisco Javier
    Aranda, Enrique
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [45] Final report of Phase I/II study of docetaxel and S-1 for patients with advanced gastric cancer
    Sakata, Y.
    Yamaguchi, K.
    Hyodo, I.
    Koizumi, W.
    Narahara, H.
    Dol, T.
    Komatsu, Y.
    Kato, T.
    Saitoh, S.
    Akiya, T.
    EJC SUPPLEMENTS, 2005, 3 (02): : 213 - 213
  • [46] A phase I trial of celecoxib in combination with docetaxel and irinotecan in patients with advanced cancer
    Dy, GK
    Mandrekar, S
    Peethambaram, PP
    Okuno, SH
    Croghan, GC
    Hanson, LJ
    Furth, A
    Adjei, AA
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 56 (06) : 623 - 628
  • [47] A phase I trial of celecoxib in combination with docetaxel and irinotecan in patients with advanced cancer
    Grace K. Dy
    Sumithra Mandrekar
    Prema P. Peethambaram
    Scott H. Okuno
    Gary C. Croghan
    Lorelei J. Hanson
    Alfred Furth
    Alex A. Adjei
    Cancer Chemotherapy and Pharmacology, 2005, 56 : 623 - 628
  • [48] Phase II study of trastuzumab in combination with capecitabine and oxaliplatin in patients with advanced gastric cancer
    Ryu, Min-Hee
    Ryoo, Baek-Yeol
    Park, Young Soo
    Park, Sook Ryun
    Kim, Jong Gwang
    Han, Hye-Suk
    Chung, Ik-Joo
    Song, Eun-Kee
    Lee, Kyung Hee
    Kang, Seok Yun
    Kang, Yoon-Koo
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [49] A phase II study of oxaliplatin with ELF regimen in patients with advanced gastric cancer.
    Pan, HM
    Zhu, N
    Lou, F
    Guo, Y
    Jin, W
    Lou, HZ
    Zheng, Y
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 364S - 364S
  • [50] A multiple-center phase II study of weekly docetaxel and oxaliplatin as first-line treatment in patients with advanced gastric cancer
    Jen-Shi Chen
    Yen-Yang Chen
    Jen-Sheng Huang
    Kun-Yun Yeh
    Ping-Tsung Chen
    Wen-Chi Shen
    Hung-Chih Hsu
    Yung-Chung Lin
    Hung-Ming Wang
    Gastric Cancer, 2012, 15 : 49 - 55
12345